These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 28142309)
1. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity. Blom J; Törnberg S J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309 [TBL] [Abstract][Full Text] [Related]
2. Five-year experience of organized colorectal cancer screening in a Swedish population - increased compliance with age, female gender, and subsequent screening round. Blom J; Kilpeläinen S; Hultcrantz R; Törnberg S J Med Screen; 2014 Sep; 21(3):144-50. PubMed ID: 25070434 [TBL] [Abstract][Full Text] [Related]
3. Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate. Blom J; Löwbeer C; Elfström KM; Sventelius M; Öhman D; Saraste D; Törnberg S J Med Screen; 2019 Jun; 26(2):92-97. PubMed ID: 30336730 [TBL] [Abstract][Full Text] [Related]
4. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing. van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499 [TBL] [Abstract][Full Text] [Related]
5. Interval cancers after negative immunochemical test compared to screen and non-responders' detected cancers in Slovenian colorectal cancer screening programme. Mlakar DN; Bric TK; Škrjanec AL; Krajc M Radiol Oncol; 2018 Jul; 52(4):413-421. PubMed ID: 30511936 [TBL] [Abstract][Full Text] [Related]
6. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Wong BC; Wong WM; Cheung KL; Tong TS; Rozen P; Young GP; Chu KW; Ho J; Law WL; Tung HM; Lai KC; Hu WH; Chan CK; Lam SK Aliment Pharmacol Ther; 2003 Nov; 18(9):941-6. PubMed ID: 14616158 [TBL] [Abstract][Full Text] [Related]
7. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476 [TBL] [Abstract][Full Text] [Related]
8. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening. Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005 [TBL] [Abstract][Full Text] [Related]
9. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Tinmouth J; Lansdorp-Vogelaar I; Allison JE Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750 [TBL] [Abstract][Full Text] [Related]
10. Initial participation as a predictor for continuous participation in population-based colorectal cancer screening. Saraste D; Öhman DJ; Sventelius M; Elfström KM; Blom J; Törnberg S J Med Screen; 2018 Sep; 25(3):126-133. PubMed ID: 28786766 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England. Murphy J; Halloran S; Gray A BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605 [TBL] [Abstract][Full Text] [Related]
12. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Brenner H; Tao S Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981 [TBL] [Abstract][Full Text] [Related]
13. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme. Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598 [No Abstract] [Full Text] [Related]
14. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme. van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071 [TBL] [Abstract][Full Text] [Related]
15. Interval cancers in a community-based programme of colorectal cancer screening with faecal occult blood test. Tazi MA; Faivre J; Lejeune C; Bolard P; Phelip JM; Benhamiche AM Eur J Cancer Prev; 1999 Apr; 8(2):131-5. PubMed ID: 10335459 [TBL] [Abstract][Full Text] [Related]
16. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results. Brenner H; Hoffmeister M; Birkner B; Stock C Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771 [TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching. Leuraud K; Jezewski-Serra D; Viguier J; Salines E Cancer Epidemiol; 2013 Dec; 37(6):959-67. PubMed ID: 24035240 [TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial). Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368 [TBL] [Abstract][Full Text] [Related]
19. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542 [TBL] [Abstract][Full Text] [Related]